1 |
Xu S, Li YM, Bie ZX, Li XG. Standard treatment-refractory/ineligible small cell lung cancer treated with drug-eluting beads bronchial arterial chemoembolization: a retrospective cohort study. Quant Imaging Med Surg 2023;13:339-51. [PMID: 36620174 DOI: 10.21037/qims-22-530] [Reference Citation Analysis]
|
2 |
Wei Z, Iezzi R, Ye X. Editorial: Local ablative therapies for the management of lung cancer. Front Oncol 2023;13:1160932. [PMID: 36874137 DOI: 10.3389/fonc.2023.1160932] [Reference Citation Analysis]
|
3 |
Ma X, Zheng D, Zhang J, Dong Y, Li L, Jie B, Jiang S. Clinical outcomes of vinorelbine loading CalliSpheres beads in the treatment of previously treated advanced lung cancer with progressive refractory obstructive atelectasis. Front Bioeng Biotechnol 2022;10:1088274. [PMID: 36605253 DOI: 10.3389/fbioe.2022.1088274] [Reference Citation Analysis]
|
4 |
Xie P, Zhang Y, He L, Zheng P. Prognostic Evaluation of CT Imaging Big Data-Assisted Arterial Chemoembolization Combined with 125I Seed Implantation for Non-Small-Cell Lung Cancer. Computational and Mathematical Methods in Medicine 2022;2022:1-8. [DOI: 10.1155/2022/3472982] [Reference Citation Analysis]
|
5 |
Fu Z, Wang C, Wei W, Xiang G, Guan L, Zhan M, Li W, Peng X, Gong Z, Gao B. Efficacy and safety of drug-eluting beads bronchial arterial chemoembolization versus conventional bronchial arterial chemoembolization in lung cancer patients with hemoptysis. Future Oncol 2022. [PMID: 35815668 DOI: 10.2217/fon-2021-1515] [Reference Citation Analysis]
|
6 |
Lorenz JM, Navuluri R. Advancements in Interventional Oncology of the Chest: Transarterial Chemoembolization and Related Therapies. Semin intervent Radiol 2022;39:253-60. [DOI: 10.1055/s-0042-1751259] [Reference Citation Analysis]
|